Sanofi and Novavax Announce Covid-19 Vaccine Agreement
Sanofi’s has entered into a co-exclusive licensing agreement with Novavax, a biotechnology company headquartered in Maryland, US. The terms of the agreement include: a co-exclusive license to co-commercialise Novavax’s current stand-alone adjuvanted COVID-19 vaccine worldwide (except in countries with existing Advance…
Teva and Medincell Announce Positive Phase 3 Efficacy Results for Schizophrenia Therapy
Teva Pharmaceuticals and Medincell have announced results from the efficacy portion of the Phase 3 Subcutaneous OLAnzapine extended-Release Injection Study (SOLARIS) trial evaluating TEV-‘749 in adult patients with schizophrenia compared to placebo. Results demonstrated that TEV-‘749 met its primary endpoint…
Regeneron Gene Therapy Improves Patient Hearing
Regeneron Pharmaceuticals have announced that the investigational gene therapy DB-OTO improved hearing to normal levels in one child (dosed at 11 months of age) within 24 weeks, and initial hearing improvements were observed in a second child (dosed at 4 years…
Oregon Therapeutics and Lantern Pharma Launch AI Collaboration
Lantern Pharma have announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimise the development of its first-in-class protein disulfide isomerase (PDI) inhibitor drug candidate XCE853 in novel and targeted cancer indications. Lantern will be leveraging its proprietary RADR AI platform to uncover…
AstraZeneca to Withdraw Covid-19 Vaccine Globally
AstraZeneca have initiated a programme of withdrawing covid-19 vaccines globally this week due to a wide-scale surplus in demand following the pandemic. The company also said it would proceed to withdraw the vaccine Vaxzevria’s marketing authorisations within Europe. AstraZeneca’s application…
.jpg?cb=bfc48e843037161287e2d37ab33cedeb&w=1200)
Broken String Biosciences and the Francis Crick Institute Collaborate
Broken String Biosciences have announced it has entered a research collaboration with the Francis Crick Institute, a world-leading biomedical discovery institute dedicated to understanding the biology underlying health and disease. In partnership with leading researchers at the Crick, the project…
.jpg?cb=82b66679a0d5348720b13228aad03de8&w=1200)
AstraZeneca Completes Equity Investment Agreement with Cellectis
AstraZeneca have announced the successful completion of an equity investment with Cellectis, a clinical-stage biotechnology company. The equity investment and a research collaboration agreement, announced in November 2023 will leverage the Cellectis proprietary gene editing technologies and manufacturing capabilities, to design up…
Merck Invests € 300 Million in New German Research Centre
Merck is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing antibodies, mRNA applications and additional products…
Boston Micro Fabrication Launches BMF Biotechnology to Advance Use of 3D BioChips in Pharma Research
Boston Micro Fabrication (BMF) has introduced BMF Biotechnology Inc. Headquartered in San Diego, California, BMF Biotechnology Inc. is dedicated to developing and commercialising innovative BioChips (organ-on-a-chip platforms) through cultivating large-scale tissues in vitro, helping accelerate new drug and cosmetic development. BMF…
TLX Cargo Invents SOLARAP – European Pharmaceutical Manufacturer
UV radiation poses a significant threat to our skin, with melanin pigments providing partial protection by absorbing and reflecting incoming radiation. Drawing inspiration from this natural defence, TLX Cargo developed SOLARAP, the next generation solar barrier material used in TLX8…